MedTrace Logo

An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method

NCT02574715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1039

Last updated 2017-06-29

No results posted yet for this study

Summary

This is a cross-sectional, multicenter observational study to assess quality of life in young Spanish women (aged 18 to 29) who use Jaydess® as their contraceptive method. The study will be conducted in standard clinical practice conditions at the private gynecology clinics and during a single study visit.

Approximately 1,200 women who have been using the intrauterine delivery system (IUS) Jaydess® as their contraceptive method of choice for 6 (±1) months will be included in the study.

Conditions

  • Quality of Life

Interventions

DRUG

Levonorgestrel (Jaydess, BAY86-5028)

Intrauterine delivery system Jaydess (13.5 mg levonorgestrel)

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-18
Primary Completion
2016-07-01
Completion
2016-09-28

Countries

  • Spain

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574715 on ClinicalTrials.gov